4.8 Article

BRCA1 Haploinsufficiency Is Masked by RNF168-Mediated Chromatin Ubiquitylation

Journal

MOLECULAR CELL
Volume 73, Issue 6, Pages 1267-+

Publisher

CELL PRESS
DOI: 10.1016/j.molcel.2018.12.010

Keywords

-

Funding

  1. Salvador Madariaga Program from the Spanish Ministry of Education, Culture and Sports [PRX18/00364]
  2. Intramural Research Program of the NIH
  3. Ellison Medical Foundation Senior Scholar in Aging Award [AG-SS-2633-11]
  4. Department of Defense [W81XWH-15-2-006, W81XWH-16-1-599]
  5. Alex Lemonade Stand Foundation Award
  6. NIH Intramural FLEX Award
  7. Rutgers Cancer Institute
  8. NCI-CCR Partnership on DNA Repair and Genomic Instability in Cancer
  9. NATIONAL CANCER INSTITUTE [ZIABC010959] Funding Source: NIH RePORTER

Ask authors/readers for more resources

BRCA1 functions at two distinct steps during homologous recombination (HR). Initially, it promotes DNA end resection, and subsequently it recruits the PALB2 and BRCA2 mediator complex, which stabilizes RAD51-DNA nucleoprotein filaments. Loss of 53BP1 rescues the HR defect in BRCA1-deficient cells by increasing resection, suggesting that BRCA1's downstream role in RAD51 loading is dispensable when 53BP1 is absent. Here we show that the E3 ubiquitin ligase RNF168, in addition to its canonical role in inhibiting end resection, acts in a redundant manner with BRCA1 to load PALB2 onto damaged DNA. Loss of RNF168 negates the synthetic rescue of BRCA1 deficiency by 53BP1 deletion, and it predisposes BRCA1 heterozygous mice to cancer. BRCA1(+/-) RNF168(-/-) cells lack RAD51 foci and are hypersensitive to PARP inhibitor, whereas forced targeting of PALB2 to DNA breaks in mutant cells circumvents BRCA1 haploinsufficiency. Inhibiting the chromatin ubiquitin pathway may, therefore, be a synthetic lethality strategy for BRCA1-deficient cancers.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.8
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available